Abaxis Inc (ABAX.O)

ABAX.O on Nasdaq

35.12USD
27 Jun 2012
Price Change (% chg)

$0.06 (+0.17%)
Prev Close
$35.06
Open
$35.06
Day's High
$35.24
Day's Low
$34.76
Volume
113,005
Avg. Vol
119,019
52-wk High
$36.29
52-wk Low
$19.68

ABAX.O

Chart for ABAX.O

About

Abaxis, Inc. (Abaxis) develops, manufactures, markets and sells blood analysis systems for use in the human or veterinary patient-care setting to provide clinicians with rapid blood constituent measurements. The Company’s segments include the medical market and the veterinary market. The Company has developed a blood analysis... (more)

Overall

Beta: 1.17
Market Cap (Mil.): $767.43
Shares Outstanding (Mil.): 21.89
Dividend: --
Yield (%): --

Financials

  ABAX.O Industry Sector
P/E (TTM): 59.84 12.06 43.38
EPS (TTM): 0.59 -- --
ROI: 7.79 6.68 9.53
ROE: 7.97 -10.79 11.11
Search Stocks

Competitors

  Price Change
Abbott Laboratories (ABT.N) $62.87 +0.52
Johnson & Johnson (JNJ.N) $66.84 +0.42
Roche Holding Ltd. (ROG.VX) -- --
IDEXX Laboratories, Inc. (IDXX.OQ) $95.28 +1.53
Heska Corporation (HSKA.O) $10.95 -0.30
Alere Inc (ALR.N) $18.34 +0.44
Alere Inc (ALR_pb.N) $203.60 +0.18

  Earnings  vs    Estimates

Analyst Research Reports

Report Title Price
Thomson Reuters Stock Report - ABAXIS, INC. (ABAX-O)
Provider: Thomson Reuters Stock Report
$25.00
Buy
ValuEngine Industry Report for Medical Products
Provider: ValuEngine, Inc.
$196.00
Buy
Abaxis Inc (ABAX) Profile + Biotechnology Industry Trends Analysis 2012
Provider: Plunkett Research, Ltd.
$49.00
Buy
ValuEngine Detailed Valuation Report for ABAX
Provider: ValuEngine, Inc.
$127.00
Buy
Abaxis Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research
Search Stocks